Citadel Advisors’s Imunon IMNN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-249
| Closed | -$26K | – | 14057 |
|
|
2021
Q4 | $26K | Buy |
249
+154
| +162% | +$24K | ﹤0.01% | 13519 |
|
|
2021
Q3 | $17K | Sell |
95
-157
| -62% | -$32.6K | ﹤0.01% | 13656 |
|
|
2021
Q2 | $63K | Buy |
252
+85
| +51% | +$20.1K | ﹤0.01% | 13222 |
|
|
2021
Q1 | $45K | Buy |
167
+60
| +56% | +$20.2K | ﹤0.01% | 12940 |
|
|
2020
Q4 | $15K | Sell |
107
-98
| -48% | -$11.7K | ﹤0.01% | 10808 |
|
|
2020
Q3 | $29K | Sell |
205
-165
| -45% | -$41.7K | ﹤0.01% | 9770 |
|
|
2020
Q2 | $269K | Buy |
+370
| New | +$160K | ﹤0.01% | 8081 |
|
|
2020
Q1 | – | Sell |
-67
| Closed | -$23K | – | 9860 |
|
|
2019
Q4 | $23K | Buy |
67
+11
| +20% | +$3.34K | ﹤0.01% | 8919 |
|
|
2019
Q3 | $17K | Buy |
+56
| New | +$19.2K | ﹤0.01% | 8973 |
|
|
2018
Q4 | – | Sell |
-105
| Closed | -$57K | – | 9423 |
|
|
2018
Q3 | $57K | Buy |
105
+28
| +36% | +$15.4K | ﹤0.01% | 8776 |
|
|
2018
Q2 | $45K | Buy |
+77
| New | +$38.2K | ﹤0.01% | 8460 |
|
|
2017
Q2 | – | Sell |
-6
| Closed | -$5K | – | 7745 |
|
|
2017
Q1 | $5K | Buy |
+6
| New | +$5.16K | ﹤0.01% | 7357 |
|
|
2016
Q4 | – | Sell |
-6
| Closed | -$19K | – | 7526 |
|
|
2016
Q3 | $19K | Buy |
+6
| New | +$20.5K | ﹤0.01% | 7067 |
|
|
2016
Q1 | – | Sell |
-3
| Closed | -$17K | – | 7315 |
|
|
2015
Q4 | $17K | Hold |
3
| – | – | ﹤0.01% | 8043 |
|
|
2015
Q3 | $15K | Sell |
3
-1
| -25% | -$5.97K | ﹤0.01% | 8325 |
|
|
2015
Q2 | $26K | Sell |
4
-1
| -20% | -$7.1K | ﹤0.01% | 8038 |
|
|
2015
Q1 | $37K | Sell |
5
-2
| -29% | -$13.9K | ﹤0.01% | 7573 |
|
|
2014
Q4 | $45K | Buy |
7
+1
| +17% | +$6.94K | ﹤0.01% | 7266 |
|
|
2014
Q3 | $51K | Sell |
6
-1
| -14% | -$8.71K | ﹤0.01% | 6893 |
|
|
2014
Q2 | $67K | Buy |
7
+3
| +75% | +$26.8K | ﹤0.01% | 6533 |
|
|
2014
Q1 | $38K | Buy |
4
+1
| +33% | +$10.4K | ﹤0.01% | 6940 |
|
|
2013
Q4 | $35K | Sell |
3
-3
| -50% | -$35.9K | ﹤0.01% | 6213 |
|
|
2013
Q3 | $87K | Sell |
6
-2
| -25% | -$29.6K | ﹤0.01% | 5440 |
|
|
2013
Q2 | $98K | Buy |
+8
| New | +$111K | ﹤0.01% | 5238 |
|
Other funds holding IMNN
XT
VHAM
TRCT
Citadel Advisors's IMNN Position: Q1 2025 in Review
Citadel Advisors sold out of Imunon (IMNN) in Q1 2025, closing a stake of 983 shares — an estimated $12.2K sold.
Citadel Advisors first reported a position in IMNN in Q2 2013 and held it in 32 quarters. The position peaked at $166K in Q1 2022. 16 funds tracked by Wall St. Rank hold IMNN as of Q1 2025.
- Citadel Advisors reported no remaining Imunon position as of Q1 2025 after selling out during the quarter.
- Citadel Advisors sold 983 Imunon shares in Q1 2025, an estimated $12.2K.
- Citadel Advisors first reported a position in Imunon in Q2 2013 and held it in 32 quarters.
- Citadel Advisors's Imunon position peaked at $166K in Q1 2022.
- 16 funds tracked by Wall St. Rank held Imunon as of Q1 2025.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.